"The HIGH TIMES Cannabis Cup" in Everett, WA - Thousands in sales in 2 days.
SAINT PETERSBURG, FL / ACCESSWIRE / September 15, 2014 / FutureWorld Corp (OTC Pink: FWDG) (PINKSHEETS: FWDG):
PersonalAnalytics:
- "Ground Breaking", "Best Product for the next couple cups" – Adam Dunn
- "The coolest thing I’ve seen in cannabis…", "Here’s a problem this solves, Labs are expensive…" – Mitch Shenassa
- "Your little Test Kits are Amazing" – customer at HIGH TIMES Cannabis Cup Seattle 2014
- "I’ve never seen anything like this" – customer at HIGH TIMES Cannabis Cup Seattle 2014
- "I’ve been to dozens of these types of shows and nobody has anything like this" – customer at HIGH TIMES Cannabis Cup Seattle 2014
- "This is about the coolest thing I’ve seen" – customer at HIGH TIMES Cannabis Cup Seattle 2014
- "It’s really exciting. It’s cheap and fast and accurate. I’m Stoked!" – customer at HIGH TIMES Cannabis Cup Seattle 2014
FutureWorld Corp (FWDG), the leading provider of advanced solutions to the Cannabis industry globally, is pleased to announce that its research team at CB Scientific, a wholly owned subsidiary of FWDG, has had a successful launch of "PersonalAnalytics THC and PersonalAnalytics CBD" test kits - the first ever quick and affordable THC & CBD Detection and Potency Kits designed specifically for use by individual consumers. “It’s a pocket-sized lab”, exclaimed customers at the Cup who were truly taken by the product.
Personal Analytics’ debut at The HIGH TIMES Cannabis Cup in Everett, WA this past Sept. 6th and 7th, 2014 resulted in over 300 demonstrations of the kits’ speed, effectiveness and simplicity now available for the entire cannabis community to enjoy. Customers and observers of the demonstrations supplied such descriptions as "Ground Breaking", "Awesome" and "Your little test kits are AMAZING!"
On Wednesday September 10th, 2014, CB Scientific was a guest on The Adam Dunn Show, a weekly podcast on icannabisradio.com offering in-depth looks at news, culture, history and trends in the cannabis industry hosted by cannabis industry icons Adam Dunn and Mitch Shenassa. Mr. Dunn referred to the Personal Analytic kits saying, “Our official vote for best product for this and probably the next couple cups.” Mr. Shenassa stated the Personal Analytics kits were, "The coolest thing I’ve seen in cannabis since my product". To have such revered industry insiders provide such glowing reviews establishes and validates the unique nature of these products solidifying a quick and seamless entry into the marketplace.
"PersonalAnalytics" has already been purchased by several dispensaries in Washington State with many others poised to carry. In addition, CB Scientific is finalizing several retail offerings for the State of Colorado that are sure to be a huge hit.
"We are confident we can meet the demands of the people and place fifty to one hundred thousand kits in the hands of consumers by year end" says Bill Short, COO of CB Scientific. The individual kits retail for $15.00 each with wholesale pricing available for quantity purchases. The kits are currently available for purchase worldwide on the CB Scientific website - cbscientific.com
ABOUT FUTUREWORLD
FutureWorld (Other OTCQB: FWDG), a Delaware corporation, is a U.S. Diversified Holding Company, listed on the Over the Counter exchange, which was formed to capitalize on the burgeoning Cannabis markets globally. FutureWorld, together with its subsidiaries, focuses on the identification, acquisition, development, and commercialization of cannabis related products, such as industrial Hemp. HempTech, a subsidiary of FutureWorld, is a technology division catered to the cannabis and the industrial Hemp market. HempTech provides smart sensor technology, communication network, surveillance security, data analysis for smart cultivation and consultation for the industrial hemp and legal medicinal marijuana. Our wireless agricultural smart sensor networks offer precision to the agricultural irrigation systems, and greenhouses for the global Hemp industry. FutureWorld and its subsidiaries do not grow, distribute or sell marijuana. To request further information about FutureWorld, please email us at [email protected], log onto our website at http://www.futureworldcorp.com/ or visit us at our Facebook page https://www.facebook.com/futureworldcorp.
ABOUT CB SCIENTIFIC
CB Scientific (http://www.cbscientific.com) is a wholly owned Florida company based in Denver Colorado. CB Scientific is continuing to develop new technologies specifically for cannabis analytics. Senior management team includes Charlie Steinberg and Derek Lebahn. Mr. Steinburg and Mr. Lebahn are some of the primary men advancing gas chromatography testing in Colorado. Mr. Steinburg has also pioneered residual solvent testing for medical cannabis and has always strived to help patients know exactly what they are buying. CB Scientific believes every product sold to patients as "Medical Quality" should be inspected for health benefits, safety, consistency, purity, potency and packaged properly for distribution.
Senior management team of CB Scientific have worked with many of the cannabis industry leaders in Colorado and have also been featured in cannabis industry publications including High Times Magazine, many trade publications, on-air interviews and panel discussions across the United States.
CB Scientific's focus has been the education and safety of consumers combined with innovation to put power into the hands of the patients. Values that FutureWorld is pleased to embrace while ever striving to raise the bar of cannabis analytics even higher.
Safe Harbor
This release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 27E of the Securities Act of 1934. Statements contained in this release that are not historical facts may be deemed to be forward-looking statements. Investors are cautioned that forward-looking statements are inherently uncertain. Actual performance and results may differ materially from that projected or suggested herein due to certain risks and uncertainties including, without limitation, ability to obtain financing and regulatory and shareholder approval for anticipated actions.
CONTACT:
FutureWorld Corp.
Investor Relations
(727) 474-1816 ext. 103
SOURCE: FutureWorld Corp.